POSC119 Cost-Effectiveness of Switching from the 10-Valent to the 13-Valent Pneumococcal Conjugate Vaccine in Sweden

Abstract

Authors

M Wasserman AC Dorange A Palmborg C McDade M Wilson E Horn

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×